Sodium-glucose co-transporter 2 inhibitors (SGLT2i) for hospitalised patients with COVID-19: prospective meta-analysis of randomised trials

Vale C., Godolphin PJ., Fisher D., Horby PW., Kosiborod MN., Hochman JS., Webster K., Higgins JPT., Althouse AD., Berwanger O., Furtado RHM., Gasparyan SB., Haynes R., Koch GG., Landray M., Leifer E., Murthy S., Neal MD., Staplin N., Diaz J., Sterne JAC., Shankar-Hari M.

Type

Journal article

Journal

Lancet Diabetes & Endocrinology

Publisher

Elsevier

Publication Date

15/07/2024

Keywords

COVID-19, SGLT2i

Permalink